Effects of various doses of 17β-estradiol on the progression of mammary carcinomas induced by single and multiple administration of 7,12-dimethylbenz[a]anthracene in female rats

Journal of Toxicologic Pathology

Volumn 13, Issue 2, 2000, Pages 67-75

  Omachi, Katsumi ^a,b   Kawaguchi, Hiroaki ^a   Funato, Mamoru ^a,c   Sato, Kenichi ^c   Okasaki, Keikou ^c   Nagaoka, Takaharu ^b   Abe, Syunichi ^b   Yoshida, Hiroki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Yoshitomi Pharmaceutical Industries Ltd   (Japan)

^c SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

Author keywords

17 estradiol; 7,12 dimethylbenz a anthracene; Mammary carcinoma; Progesterone; Progression; Rat

Indexed keywords

EID: 52849121129     PISSN: 09149198     EISSN: 09149198     Source Type: Journal    
DOI: 10.1293/tox.13.67     Document Type: Article

References (31)

1. Huggins C, Grand LC, and Brillantes FP. Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature (Lond.) 1961; 189: 204-207.
2. Meites J. Relation of prolactin and estrogen to mammary tumorigenesis in the rat. J Natl Cancer Inst 1972; 48: 1217-1224.
3. Dao TL. The role of ovarian hormones in initiating the induction of mammary cancer in rats by polynuclear hydrocarbons. Cancer Res 1962; 22: 973-981.
4. Sylvester PW, Aylsworth CF, and Meites J. Relationship of hormones to inhibition of mammary tumor development by underfeeding during the "critical period" after carcinogen administration. Cancer Res 1981; 41: 1384-1388.
5. Sylvester PW, Aylsworth CF, Van Vugt DA, and Meites J. Influence of underfeeding during the "critical period" or thereafter on carcinogen-induced mammary tumors in rats. Cancer Res 1982; 42: 4943-4947.
6. Mainland D and Murray IM. Tables for use in fourfold contingency tests. Science 1952; 116: 591-594.
7. Chen CL and Meites J. Effects of estrogen and progesterone on serum and pituitary prolactin levels in ovariectomized rats. Endocrinology 1970; 86: 503-505.
8. Meites J and Nicoll CS. Adenohypophysis: Prolactin. Ann Rev Physiol 1966; 28: 57-88.
9. Yoshida H, Kadota A, Fukunushi R, and Matsumoto K. Induction of mammary dysplasia and mammary carcinoma in neonatally androgenized female rats by 7,12-dimethylbenz[a] anthracene. J Natl Cancer Inst 1980; 64: 1105-1112.
10. Yoshida H, Fukunushi R, Kato Y, and Matsumoto K. Progesterone-stimulated growth of mammary carcinomas induced by 7,12-dimethylbenz[a] anthracene in neonatally androgenized rats. J Natl Cancer Inst 1980; 65: 823-828.
11. Furth J. The role of prolactin in mammary carcinogenesis. In: Human Prolactin, Pasteels JL and Robin C (eds.), New York: Excerpta Medica/American Elsevier Publishing Co. Inc., 223-248, 1973.
12. Welsch CW and Nagasawa H. Prolactin and murine mammary tumorigenesis: a review. Cancer Res 1977; 37: 951-963.
13. Dao TL and Sunderland H. Mammary carcinogenesis by 3-methylcholanthrene I. Hormonal aspects in tumor induction and growth. J Natl Cancer Inst 1959; 23: 567-585.
14. Huggins C, Briziarelli G, and Sutton H. Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Exptl Med 1959; 109: 25-42.
15. Welsch CW. Growth inhibition of rat mammary carcinoma induced by cis-platinum diammino-dichloride-II. J Natl Cancer Inst 1971; 47: 1071-1078
16. Welsch CW, Clemens JA, and Meites J. Effects of hypothalamic and amygdaloid lesions on development and growth of carcinogen-induced mammary tumors in the female rat. Cancer Res 1969; 29: 1541-1549.
17. Sinha D, Cooper D, and Dao TL. The nature of estrogen and prolactin effect on mammary tumorigenesis. Cancer Res 1973; 33: 411-414.
18. Nagasawa H and Yanai R. Effects of prolactin or growth hormone on growth of carcinogen-induced mammary tumors of Adreno-ovariectomized rats. Intern J Cancer 1970; 6: 488-495.
19. Nagasawa H and Yanai R. Effect of human placental lactogen on growth of carcinogen-induced mammary tumors in rats. Intern J Cancer 1973; 11: 131-137.
20. Pearson OH, Llerena O, Llerena L, Molina A, and Butler T. Prolactin-dependent rat mammary cancer: a model for man ? Trans Assoc Am Physicians 1969; 82: 225-238.
21. Kim U and Furth J. Relation of mammary tumors to mammotropes. II. Hormone responsiveness of 3-methylcholanthrene induced mammary carcinomas. Proc Soc Exptl Biol Med 1960; 103: 643-645.
22. Bradley CJ, Kledzik GS, and Meites J. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development. Cancer Res 1976; 36: 319-324.
23. Nagasawa H, Chen CL, and Meites J. Relation between growth of carcinogen-induced mammary cancers and serum prolactin values in rats. Proc Soc Exptl Biol Med 1973; 142: 625-627.
24. Sterental A, Dominguez JM, Weissman C, and Pearson OH. Pituitary role in the estrogen dependency of experimental mammary cancer. Cancer Res 1963; 23: 481-484.
25. Kledzik GS, Bradley CJ, Marshall S, Campbell GA, and Meites J. Effects of high doses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats. Cancer Res 1976; 36: 3265-3268.
26. Shigaki N, Kimura M, Takano S, Fujino N, and Akagi M. Reduction of estrogen and prolactin receptors in 7,12-Dimethylbenz[a]anthracene-induced rat mammary tumor by high doses of estrogen. Japanese Journal of Surgery 1987; 17: 395-401.
27. Turkington RW and Hilf R. Hormonal dependence of DNA synthesis in mammary carcinoma cells in vitro. Science 1968; 160: 1457-1459.
28. Welsch CW and Rivera EM. Differential effects of estrogen and prolactin on DNA synthesis in organ cultures of DMBA-induced rat mammary carcinoma. Proc Soc Exptl Biol Med 1972; 139: 623-626.
29. Okasaki K, Omachi K, Sato K, Funato M, Nagata R, and Yoshida H. Growth inhibition of a high dose of 17β estradiol and ovariectomy on 7,12-Dimethylbenz(a)anthracene-induced mammary carcinomas in female rats. J Toxicol Pathol 1998; 11: 257-262.
30. Yoshida H, Fukuhara J, Yamashi S, Yoshida A, Fukunishi R, Tsuji M, and Matsumoto K. Effects of pharmacological doses of estrogen on ovary-independent rat mammary carcinoma containing estrogen and progesterone receptors. Cancer Res 1983; 43: 2311-2316.
31. Yoshida H, Yoshida A, Yamada M, Yamanaka K, Kitamura Y, and Matsumoto K. Regression with secretory changes of ovary-independent rat mammary carcinoma by pharmacological doses of estrogen. Jpn J Cancer Res (Gann) 1985; 76: 771-778.